CNS Neurosci Ther, 2024 · DOI: 10.1111/cns.14781 · Published: May 11, 2024
Traumatic brain injury (TBI) and spinal cord injury (SCI) are injuries to the central nervous system caused by external forces, leading to impairments and potential long-term disability. The inflammatory response contributes significantly to secondary injury in TBI and SCI, prolonging the post-CNS trauma period and becoming a potential therapeutic intervention. This review aims to provide an overview of the role of the XCL1-XCR1 axis and the T-cell response in inflammation caused by TBI and SCI and identify potential targets for therapy.
The XCL1-XCR1 axis could be a promising therapeutic target for patients with TBI and SCI. Blocking this axis can improve the prognosis of these patients.
Inhibiting the XCL1-XCR1 axis may provide the key to alleviating excessive inflammatory responses in sterile neuroinflammatory diseases such as TBI and SCI.
Interventions targeting any segment of the IL-15, IL-12, T cell, NK cell, XCL1, XCR1, IFN-γ pathway could potentially lead to significant improvements in the prognosis of neurological injuries.